CDH2 and urinary bladder cancer: In our T24 bladder cancer cell model, after treatment of cells with GW501516, a decrease in the soluble N-cadherin level was detected in the extracellular compartment, suggesting a reduction in proteolytic cleavage of N-cadherin, possibly due to a decrease in the presence of Tspan15 at the plasma membrane.